[go: up one dir, main page]

ZA201207900B - Fast dissolving drug delivery systems - Google Patents

Fast dissolving drug delivery systems

Info

Publication number
ZA201207900B
ZA201207900B ZA2012/07900A ZA201207900A ZA201207900B ZA 201207900 B ZA201207900 B ZA 201207900B ZA 2012/07900 A ZA2012/07900 A ZA 2012/07900A ZA 201207900 A ZA201207900 A ZA 201207900A ZA 201207900 B ZA201207900 B ZA 201207900B
Authority
ZA
South Africa
Prior art keywords
drug delivery
delivery systems
fast dissolving
dissolving drug
fast
Prior art date
Application number
ZA2012/07900A
Inventor
Dominique Costantini
Original Assignee
Applied Pharma Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10305288A external-priority patent/EP2377526A1/en
Priority claimed from US12/729,735 external-priority patent/US20110237563A1/en
Application filed by Applied Pharma Res filed Critical Applied Pharma Res
Publication of ZA201207900B publication Critical patent/ZA201207900B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2012/07900A 2010-03-23 2012-10-19 Fast dissolving drug delivery systems ZA201207900B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10305288A EP2377526A1 (en) 2010-03-23 2010-03-23 Fast dissolving drug delivery systems
US12/729,735 US20110237563A1 (en) 2010-03-23 2010-03-23 Fast dissolving drug delivery systems
PCT/EP2011/054482 WO2011117313A1 (en) 2010-03-23 2011-03-23 Fast dissolving drug delivery systems

Publications (1)

Publication Number Publication Date
ZA201207900B true ZA201207900B (en) 2013-06-26

Family

ID=44070534

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/07900A ZA201207900B (en) 2010-03-23 2012-10-19 Fast dissolving drug delivery systems

Country Status (9)

Country Link
EP (1) EP2549988A1 (en)
KR (1) KR20130012067A (en)
CN (1) CN103025321A (en)
AU (1) AU2011231645A1 (en)
BR (1) BR112012024092A2 (en)
CA (1) CA2794042A1 (en)
RU (1) RU2560693C2 (en)
WO (1) WO2011117313A1 (en)
ZA (1) ZA201207900B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2493457B1 (en) 2009-10-30 2017-08-09 IX Biopharma Ltd Fast dissolving solid dosage form
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
WO2014057351A1 (en) * 2012-10-11 2014-04-17 Ix Biopharma Ltd Solid dosage form
CN102920683B (en) * 2012-06-11 2013-08-14 江苏豪森药业股份有限公司 Olanzapine oral instant membrane
CN102860997A (en) * 2012-09-28 2013-01-09 天津市聚星康华医药科技有限公司 Ondansetron oral cavity instant membrane capable of sheltering taste and preparation method thereof
CN102846581A (en) * 2012-09-28 2013-01-02 天津市聚星康华医药科技有限公司 Ambroxol hydrochloride oral fast-dissolving film and preparation method thereof
CN103432105A (en) * 2013-09-02 2013-12-11 天津市聚星康华医药科技有限公司 Meclozine oral film and preparation method thereof
CN104666280B (en) * 2015-03-21 2017-10-13 合肥华方医药科技有限公司 A kind of Glipizide oral cavity dissolving films and preparation method thereof
CN104958279A (en) * 2015-06-27 2015-10-07 万特制药(海南)有限公司 Loratadine oral quickly-soluble film and preparation method thereof
CN104940174A (en) * 2015-07-23 2015-09-30 合肥华方医药科技有限公司 Preparation method of donepezil oral fast dissolving film
DE102017112527B4 (en) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Fast disintegrating foam wafers with a high basis weight
JP7710850B2 (en) 2017-12-29 2025-07-22 ラクソン メディカル アーゲー Drug Delivery Systems
CN108078962A (en) * 2018-01-29 2018-05-29 中国药科大学 A kind of instant film of donepezil hydrochloride orally and preparation method thereof
CN108142940B (en) * 2018-02-05 2021-05-14 中山大学附属第三医院(中山大学肝脏病医院) Soft tablet for promoting swallowing and preparation method thereof
CA3106579A1 (en) * 2018-07-15 2020-01-23 Rapid Dose Therapeutics Corp. Cannabinoid oral dispersible film strip
WO2020158918A1 (en) 2019-01-31 2020-08-06 日精エー・エス・ビー機械株式会社 Resin container manufacturing apparatus, temperature adjusting device, resin container manufacturing method, and temperature adjusting method
CN118082156A (en) 2019-01-31 2024-05-28 日精Asb机械株式会社 Preform temperature regulating device and temperature regulating method, and resin molded container manufacturing device and manufacturing method
WO2020158920A1 (en) 2019-01-31 2020-08-06 日精エー・エス・ビー機械株式会社 Device and method for producing resin container
KR102643807B1 (en) 2019-01-31 2024-03-05 닛세이 에이. 에스. 비 기카이 가부시키가이샤 Manufacturing equipment and manufacturing method for resin containers
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2169729C (en) 1993-08-19 2001-04-03 James E. Biegajski Water-soluble pressure-sensitive mucoadhesive
US5800832A (en) 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
AU2002365936A1 (en) * 2001-11-16 2003-09-02 Eisai Co. Ltd Compositions and methods to treat gastrointestinal disorders
US6750291B2 (en) 2002-04-12 2004-06-15 Pacific Corporation Film-forming agent for drug delivery and preparation for percutaneous administration containing the same
WO2003093260A1 (en) 2002-04-30 2003-11-13 Biogal Gyogyszergyar Rt. Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
PT1648421T (en) * 2003-07-24 2017-12-22 Glaxosmithkline Llc Orally dissolving films
ES2238001B1 (en) 2004-01-21 2006-11-01 Vita Cientifica, S.L. NEW POLYMORPHIC FORMS OF ONDANSETRON, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANANTIMETICS.
DK2351555T3 (en) * 2004-02-23 2017-01-23 Euro Celtique Sa Abuse-safe transdermal opioid delivery device
DE102005033942A1 (en) * 2005-07-20 2007-02-22 Hexal Ag Non-spitting, oral, fast-disintegrating film for antiemetic or antimigraine
FR2905268B1 (en) 2006-09-01 2009-01-23 Unither Dev Soc Par Actions Si SALIVARY SUBSTITUTE
HUE038022T4 (en) 2006-10-02 2023-02-28 Spepharm Ag Non-mucoadhesive film dosage forms
US20100215774A1 (en) * 2007-02-09 2010-08-26 Todd Maibach Film comprising nitroglycerin
WO2008140460A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
US20090004254A1 (en) * 2007-06-19 2009-01-01 Todd Maibach Film comprising active drugs
US20090047350A1 (en) * 2007-08-17 2009-02-19 Ramesh Bangalore Perforated water soluble polymer based edible films
US20090047330A1 (en) * 2007-08-17 2009-02-19 Ramesh Bangalore Oral fast dissolving films for erectile dysfunction bioactive agents
WO2009043588A2 (en) * 2007-10-02 2009-04-09 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Ph regulating antibacterial films for the oral or vaginal cavity

Also Published As

Publication number Publication date
CN103025321A (en) 2013-04-03
AU2011231645A2 (en) 2012-12-20
BR112012024092A2 (en) 2016-09-06
EP2549988A1 (en) 2013-01-30
WO2011117313A1 (en) 2011-09-29
KR20130012067A (en) 2013-01-31
RU2012144848A (en) 2014-04-27
RU2560693C2 (en) 2015-08-20
AU2011231645A1 (en) 2012-10-18
CA2794042A1 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
ZA201207900B (en) Fast dissolving drug delivery systems
GB2479953B (en) Drug delivery device
GB2491327B (en) Delayed prolonged drug delivery
ZA201209197B (en) Drug delivery device
SG10201700716VA (en) Drug delivery device
PL2654864T3 (en) DRUG DELIVERY SYSTEM
HUE062316T2 (en) Drug delivery technology
PL2437736T3 (en) Drug delivery systems
ZA201309156B (en) Drug delivery system
IL227352A0 (en) Ocular drug delivery system
PT2793857T (en) Drug delivery technology
ZA201208185B (en) Intravaginall drug delivery device
EP2547384A4 (en) Gas-pressured medication delivery device
IL233599A0 (en) A drug delivery system
EP2626055A4 (en) Drug delivery device
HK1175396A (en) Fast dissolving drug delivery systems
GB201018750D0 (en) Drug delivery system
HK1194672A (en) Drug delivery system
HK1190348A (en) Drug delivery device
HK1181329A (en) Drug delivery device
AU2010904901A0 (en) Drug delivery device
HK1190350A (en) Drug delivery device